<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="68649">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01697540</url>
  </required_header>
  <id_info>
    <org_study_id>KMUHIRB-2012-05-05(I)</org_study_id>
    <nct_id>NCT01697540</nct_id>
  </id_info>
  <brief_title>Management of Highly Active Anti-retroviral Therapy-related Hyperlipidemia Among HIV-infected Patients in Taiwan</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>Kaohsiung Medical University Chung-Ho Memorial Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Kaohsiung Medical University Chung-Ho Memorial Hospital</source>
  <oversight_info>
    <authority>United States: Food and Drug Administration</authority>
  </oversight_info>
  <brief_summary>
    <textblock>
      1. Written informed consent must be obtained before any study specific procedures are
           undertaken.

        2. The process of the experiment (brief describe) The patients must come back for follow
           during 4 to 12 weeks after starting the new therapy. The investigators will follow the
           patients' lipid profile and any side effects and stop the observation till 36 months
           after starting the new therapy. The serum level of HIV-VL, CD4, GOT, GPT, triglyceride,
           cholesterol, HDL-cholesterol, and LDL-cholesterol will be checked every 3 months. The
           patients' chart and all data will be delinked to protect the patients' right and
           privacy.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>September 2012</start_date>
  <primary_completion_date type="Anticipated">August 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <study_design>Observational Model: Case-Only, Time Perspective: Prospective</study_design>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">100</enrollment>
  <condition>HIV</condition>
  <eligibility>
    <study_pop>
      <textblock>
        HIV/AIDS group
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  HIV-infected patients who receive HAART therapy but have metabolic side effects.

          -  Age over 20 years old

        Exclusion Criteria:

          -  Abnormal liver function: GOT or GPT 5 times over normal upper limit
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Jih- jin Tsai, MD</last_name>
    <phone>886-7-3121101</phone>
    <phone_ext>6638</phone_ext>
    <email>jijits@cc.kmu.edu.tw</email>
  </overall_contact>
  <location>
    <facility>
      <name>Tropical medicine center</name>
      <address>
        <city>Kaohsiung</city>
        <country>Taiwan</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jih- Jin Tsai, MD</last_name>
      <phone>886-7-3121101</phone>
      <phone_ext>6638</phone_ext>
      <email>jijits@cc.kmu.edu.tw</email>
    </contact>
  </location>
  <location_countries>
    <country>Taiwan</country>
  </location_countries>
  <verification_date>September 2012</verification_date>
  <lastchanged_date>October 1, 2012</lastchanged_date>
  <firstreceived_date>September 28, 2012</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <is_fda_regulated>Yes</is_fda_regulated>
  <is_section_801>No</is_section_801>
  <has_expanded_access>No</has_expanded_access>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
